Effectiveness of erenumab in chronic migraine in a tertiary headache centre

被引：0
|
作者：
Khalil, Modar [1 ,2 ]
Moreno-Ajona, David [1 ,2 ]
Greenwood, Fiona [1 ,2 ]
Hoffmann, Jan [1 ,2 ]
Goadsby, Peter J. [1 ,2 ]
机构：
[1] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[2] Kings Coll London, SLaM Biomed Res Ctr, London, England
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-PO-412
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [31] Illness perception in patients with migraine: An exploratory study in a tertiary care headache centre
    Sirri, Laura
    Pierangeli, Giulia
    Cevoli, Sabina
    Cortelli, Pietro
    Grandi, Silvana
    Tossani, Eliana
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2018, 111 : 52 - 57
  • [32] Effectiveness of prophylactic trigger points inactivation in chronic migraine and chronic daily headache with migraine features
    Calandre, EP
    Hidalgo, J
    Garcia-Leiva, JM
    Muñuzuri, D
    Moreno, V
    CEPHALALGIA, 2003, 23 (07) : 713 - 713
  • [33] REAL-WORLD EFFECTIVENESS OF ERENUMAB IN CHRONIC MIGRAINE PROPHYLAXIS IN CROATIA: A PROSPECTIVE STUDY
    Bracic, Matea
    Lakusic, Darija Mahovic
    Jakus, Lukrecija
    CEPHALALGIA, 2020, 40 : 75 - 76
  • [34] Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study
    Viudez-Martinez, Adrian
    Pascual-Carrasco, Angela
    Beltran-Blasco, Isabel
    Hernandez-Lorido, Raquel
    de Apodaca, Rosa F. Ruiz
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 814 - 823
  • [35] Treatment responses to erenumab in onabotulinumtoxinA-refractory chronic migraine: Long-term real-world experience from a specialist headache centre
    Cheng, Fan
    Tang, Ker
    Wan, Shunwei
    Hu, Weihai
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 227 - 227
  • [36] Chronic migraine treatment with erenumab: Responder rates
    Diener, Hans-Christoph
    Brandes, Jan
    Dolezil, David
    Freeman, Marshall C.
    McAllister, Peter J.
    Winner, Paul
    Cheng, Sunfa
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [37] Chronic Migraine Treatment with Erenumab: Responder Rates
    Brandes, Jan L.
    Diener, Hans-Christoph
    Dolezil, David
    Freeman, Marshall C.
    Mcallister, Peter J.
    Winner, Paul
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 36 - 37
  • [38] EARLY AUSTRALIAN EXPERIENCE WITH ERENUMAB FOR CHRONIC MIGRAINE
    Cheng, Shuli
    Jenkins, Bronwyn
    Hutton, Elspeth
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (E7):
  • [39] Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes
    Bigal, ME
    Rapoport, AM
    Sheftell, FD
    Tepper, SJ
    Lipton, RB
    CEPHALALGIA, 2004, 24 (06) : 483 - 490
  • [40] Chronic Migraine Treatment with Erenumab: Responder Rates
    Brandes, J. L.
    Diener, H.
    Dolezil, D.
    Freeman, M. C.
    McAllister, P. J.
    Winner, P.
    Cheng, S.
    Leonardi, D. K.
    Lenz, R. A.
    Mikol, D. D.
    HEADACHE, 2017, 57 : 197 - 198
12345